Please assess the completion status of the following clinical trial:

Trial Title: Studies With 1,25-Dihydroxycholecalciferol

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
* INCLUSION CRITERIA:~Patients with hereditary resistance to calcitrol.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Drug treatment (Type: EXPERIMENTAL): 1,25-Dihydroxycholecalciferol 5 ug orally per day for 2 years

Based on this trial design, predict the completion outcome and termination type (if applicable).